Integrating Pharmacotherapy with Multidisciplinary Rehabilitation after Oral Cancer Treatment

Background: Oral cancer treatment frequently causes persistent impairments in swallowing, mastication, speech, salivary and oral function, nutrition, physical capacity, and social participation. Rehabilitation is increasingly recognized as a continuum of care spanning pre-treatment, active treatment, and survivorship, yet medication management is rarely considered explicitly within the rehabilitation pathway. Objective: This narrative review examined how pharmacotherapy and pharmaceutical care may be integrated with multidisciplinary rehabilitation after oral cancer treatment. Methods: Targeted literature searches identified evidence on oral and head and neck cancer rehabilitation, treatment-related symptoms, supportive pharmacotherapy, medication-related problems, and clinical-pharmacy services. Systematic reviews, meta-analyses, randomized trials, clinical guidance, and directly relevant observational studies were prioritized, and the evidence was synthesized thematically with emphasis on functional outcomes and multidisciplinary care. Results: Current evidence supports rehabilitation addressing swallowing, jaw mobility, speech, oral health, nutrition, exercise, shoulder function, and participation, although intervention protocols and outcome measures remain heterogeneous. Symptom-directed pharmacotherapy is relevant to pain, xerostomia, and mucositis. Medication-related problems are also common in head and neck cancer, and clinical-pharmacist services can identify and address these problems. However, direct evidence linking structured pharmaceutical care to rehabilitation participation and functional outcomes remains limited. Discussion: A five-stage, function-oriented pharmacotherapy–rehabilitation interface is therefore proposed as a hypothesis-generating framework rather than an established treatment algorithm. Conclusion: Integrating medication review with multidisciplinary rehabilitation may improve coordination of supportive care, but prospective studies are needed to determine whether this approach improves functional and patient-reported outcomes.

Authors

Institutions

Publication Details

Journal
JURNAL FARMASIMED (JFM)
Published
2026-10-30
DOI
https://doi.org/10.35451/jfm.v9i1.3945
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrating Pharmacotherapy with Multidisciplinary Rehabilitation after Oral Cancer Treatment

Muhammad Adib Dwi Tamma Putra, Ade Nabilah Vania Utami
2 links
JURNAL FARMASIMED (JFM)
Cancer survivorship and care
article

Integrating Pharmacotherapy with Multidisciplinary Rehabilitation after Oral Cancer Treatment

Muhammad Adib Dwi Tamma Putra, Ade Nabilah Vania Utami
article en

Abstract

Background: Oral cancer treatment frequently causes persistent impairments in swallowing, mastication, speech, salivary and oral function, nutrition, physical capacity, and social participation. Rehabilitation is increasingly recognized as a continuum of care spanning pre-treatment, active treatment, and survivorship, yet medication management is rarely considered explicitly within the rehabilitation pathway. Objective: This narrative review examined how pharmacotherapy and pharmaceutical care may be integrated with multidisciplinary rehabilitation after oral cancer treatment. Methods: Targeted literature searches identified evidence on oral and head and neck cancer rehabilitation, treatment-related symptoms, supportive pharmacotherapy, medication-related problems, and clinical-pharmacy services. Systematic reviews, meta-analyses, randomized trials, clinical guidance, and directly relevant observational studies were prioritized, and the evidence was synthesized thematically with emphasis on functional outcomes and multidisciplinary care. Results: Current evidence supports rehabilitation addressing swallowing, jaw mobility, speech, oral health, nutrition, exercise, shoulder function, and participation, although intervention protocols and outcome measures remain heterogeneous. Symptom-directed pharmacotherapy is relevant to pain, xerostomia, and mucositis. Medication-related problems are also common in head and neck cancer, and clinical-pharmacist services can identify and address these problems. However, direct evidence linking structured pharmaceutical care to rehabilitation participation and functional outcomes remains limited. Discussion: A five-stage, function-oriented pharmacotherapy–rehabilitation interface is therefore proposed as a hypothesis-generating framework rather than an established treatment algorithm. Conclusion: Integrating medication review with multidisciplinary rehabilitation may improve coordination of supportive care, but prospective studies are needed to determine whether this approach improves functional and patient-reported outcomes.

JURNAL FARMASIMED (JFM)Vol. 9(1)
Sriwijaya University (ID)
Good health and well-being
Openalex Percentile: Top 16%
Cancer survivorship and care
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon